ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. (Q53734368)

18 May 2018

title

ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. (English)

1 reference

18 May 2018

5

Remuzzi G

1 reference

18 May 2018

Remuzzi A

1

1 reference

18 May 2018

Fassi A

series ordinal

2

1 reference

18 May 2018

Bertani T

series ordinal

3

1 reference

18 May 2018

Perico N

series ordinal

4

1 reference

18 May 2018

publication date

1 October 1999

1 reference

18 May 2018

American Journal of Kidney Diseases

published in

1 reference

18 May 2018

volume

34

1 reference

18 May 2018

issue

4

1 reference

18 May 2018

page(s)

626-632

1 reference

18 May 2018

Understanding the nature of renal disease progression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Does an adequate control of blood pressure protect the kidney in essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Reversing glomerular hypertension stabilizes established glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

Converting enzyme inhibition and progressive glomerulosclerosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970385-9

7 January 2021

10.1016/S0272-6386(99)70385-9

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018